PRC2 Loss and DNMT Inhibition Boost Viral Mimicry in Cancer

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

In this issue of Cancer Discovery, Patel and colleagues explore the synergistic lethality of PRC2 inactivation and DNMT inhibition in malignant peripheral nerve sheath tumor cells. Reactivation of retrotranspo-sons under this dual control suggests that the viral mimicry response contributes to enhanced cytotoxicity with potential clinical implications.

Cite

CITATION STYLE

APA

Guil, S., & Esteller, M. (2022). PRC2 Loss and DNMT Inhibition Boost Viral Mimicry in Cancer. Cancer Discovery, 12(9), 2020–2022. https://doi.org/10.1158/2159-8290.CD-22-0733

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free